These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37009361)

  • 1. Pulmonary Cryptococcosis and Pulmonary Fibrosis: A Complication of COVID-19 Pneumonia.
    Isaac S; Pasha MA; Isaac S; Kyei-Nimako E; Lal A
    Cureus; 2023 Mar; 15(3):e35660. PubMed ID: 37009361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-Month Outcomes of Post-ARDS Pulmonary Fibrosis in Patients With H1N1 Pneumonia.
    Gao J; Chu W; Duan J; Li J; Ma W; Hu C; Yao M; Xing L; Yang Y
    Front Mol Biosci; 2021; 8():640763. PubMed ID: 34169092
    [No Abstract]   [Full Text] [Related]  

  • 3. Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection.
    Ahmad Alhiyari M; Ata F; Islam Alghizzawi M; Bint I Bilal A; Salih Abdulhadi A; Yousaf Z
    IDCases; 2021; 23():e01041. PubMed ID: 33425682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
    Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report.
    Nan D; Abraira-Meriel C; de la Roz-Fernández S; Maestre-Orozco T; Hernandez JL; Fernandez-Ayala M
    Eur J Case Rep Intern Med; 2021; 8(10):002821. PubMed ID: 34790623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of laboratory diagnosis, clinical manifestation, and management of pulmonary cryptococcosis: Report of the clinical scenario and literature review.
    Hsiao PJ; Cheng H; Kao YH; Wang YH; Chiu CC; Chiang WF; Kuo CC; Chuu CP; Wu KA
    Clin Chim Acta; 2022 Jan; 524():78-83. PubMed ID: 34843703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.
    Giacomelli C; Piccarducci R; Marchetti L; Romei C; Martini C
    Biochem Pharmacol; 2021 Nov; 193():114812. PubMed ID: 34687672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated Pulmonary Cryptococcosis: A Rare Case Presentation.
    Sharma S; Agrawal G; Das S
    Indian J Crit Care Med; 2022 Jan; 26(1):129-132. PubMed ID: 35110857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report.
    Doane JJ; Hirsch KS; Baldwin JO; Wurfel MM; Pipavath SN; West TE
    Am J Case Rep; 2021 Dec; 22():e933458. PubMed ID: 34848676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
    Wu C; Chen X; Cai Y; Xia J; Zhou X; Xu S; Huang H; Zhang L; Zhou X; Du C; Zhang Y; Song J; Wang S; Chao Y; Yang Z; Xu J; Zhou X; Chen D; Xiong W; Xu L; Zhou F; Jiang J; Bai C; Zheng J; Song Y
    JAMA Intern Med; 2020 Jul; 180(7):934-943. PubMed ID: 32167524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome.
    Kazi AW; Summer R; Sundaram B; George G
    Am J Med Sci; 2023 Mar; 365(3):307-312. PubMed ID: 36535539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection.
    Lechowicz K; Drożdżal S; Machaj F; Rosik J; Szostak B; Zegan-Barańska M; Biernawska J; Dabrowski W; Rotter I; Kotfis K
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the prone position on patients with hydrostatic pulmonary edema compared with patients with acute respiratory distress syndrome and pulmonary fibrosis.
    Nakos G; Tsangaris I; Kostanti E; Nathanail C; Lachana A; Koulouras V; Kastani D
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):360-8. PubMed ID: 10673172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Cases of COVID-19 Pneumonia in Female Patients in Italy Who Had Pulmonary Fibrosis on Follow-Up Lung Computed Tomography Imaging.
    Picchi G; Mari A; Ricciardi A; Carucci AC; Sinatti G; Cosimini B; Di Norcia M; Iapadre N; Balsano C; Grimaldi A
    Am J Case Rep; 2020 Nov; 21():e926921. PubMed ID: 33219200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs.
    Shen H; Zhang N; Liu Y; Yang X; He Y; Li Q; Shen X; Zhu Y; Yang Y
    Front Pharmacol; 2021; 12():805535. PubMed ID: 35069217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review.
    Atabati E; Dehghani-Samani A; Mortazavimoghaddam SG
    Can J Respir Ther; 2020; 56():1-9. PubMed ID: 33274259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult respiratory distress syndrome caused by pulmonary cryptococcosis in an immunocompetent host: a case report.
    Yu FC; Perng WC; Wu CP; Shen CY; Lee HS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Aug; 52(2):120-4. PubMed ID: 8402366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.
    Hasegawa T; Nakagawa A; Suzuki K; Yamashita K; Yamashita S; Iwanaga N; Tamada E; Noda K; Tomii K
    Cytokine; 2021 Dec; 148():155618. PubMed ID: 34127355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.